PEPTIDES
Detail
| Product name | Liraglutide |
| Cas No. | 204656-20-2 |
| Sequence | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(palm-gama-Glu)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
| Structural formula |  |
| Appearance | White powder |
| Purity | 98%min HPLC |
| Storage | In an air tight container,protected from light at temperature 2-8℃ |
| Description | Liraglutide is a new type of hypoglycemic drug that activates AMP-activated protein kinase thus enhancing insulin sensitivity. It not only has a significant hypoglycemic effect, but also has the functions of weight loss, blood pressure reduction, and improvement of blood lipid profile. |
